These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 113305)

  • 41. [Epidemiological evaluation of thromboembolic risk. Critical review of the prospects offered by determination of antithrombin III].
    Gabrielli L; Lorenzi G; Sarcina A; Rossi E; Margstakler E; Mondonico P
    Minerva Med; 1980 Jan; 71(2):83-8. PubMed ID: 7354931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Sakaguchi reaction. III. Structural study by nuclear magnetic resonance of coloured compounds (author's transl)].
    Dupin JP; Casadebaig F; Pometan JP; Petraud M; Barbe B; Moulines J
    Ann Pharm Fr; 1979; 37(11-12):523-30. PubMed ID: 546290
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antithrombin III and heparin].
    Zhu KC
    Zhonghua Fu Chan Ke Za Zhi; 1988 May; 23(3):177-9. PubMed ID: 3058418
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the metabolites of Streptomyces luteoreticuli Kato et Arai. III. The structure of luteoreticulum. (2) (author's transl)].
    Koyama Y; Kyomura N; Oishi J; Yamagishi S
    Yakugaku Zasshi; 1975 Oct; 95(10):1210-7. PubMed ID: 1238532
    [No Abstract]   [Full Text] [Related]  

  • 45. [Carboxypeptidase Cn. III. Esterolytic activity (author's transl)].
    Kubota Y; Shoji S; Funakoshi T; Ueki H
    Yakugaku Zasshi; 1974 Aug; 94(8):964-69. PubMed ID: 4472558
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological action and clinical significance of antithrombin III.
    Abildgaard U
    Haematologia (Budap); 1984; 17(1):77-9. PubMed ID: 6724354
    [No Abstract]   [Full Text] [Related]  

  • 47. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antithrombin III. Functional role and methods of determination (review)].
    Belitser VA; Musialkovskaia AA; Platonova TN; Ena IaM
    Vopr Med Khim; 1987; 33(4):8-15. PubMed ID: 3310396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of antithrombin III as a regulator of in vivo coagulation.
    Bauer KA; Rosenberg RD
    Semin Hematol; 1991 Jan; 28(1):10-8. PubMed ID: 2017686
    [No Abstract]   [Full Text] [Related]  

  • 50. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system".
    Rosenberg RD; Bauer KA; Marcum JA
    J Med; 1985; 16(1-3):351-416. PubMed ID: 3915998
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical evaluations of antithrombin III activity in acute liver injuries (author's transl)].
    Iwabuchi S; Mizuguchi A; Okabe K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Oct; 77(10):1667. PubMed ID: 7452954
    [No Abstract]   [Full Text] [Related]  

  • 52. [Thiocyanatochromium(III)complexes in chemical analysis, XXXII: Indirect volumetric determination of tetracycline (author's transl)].
    Gănescu I; Braun M; Gavrilă E
    Arch Pharm (Weinheim); 1977 Jul; 310(7):544-8. PubMed ID: 901148
    [No Abstract]   [Full Text] [Related]  

  • 53. [Sulfonyl ketenethioacetal III. Reaction of sulfonyl ketenethioacetal with active methylene compounds (author's transl)].
    Hidaki S; Tominaga Y; Matsuda Y; Kobayashi G; Sakemi K
    Yakugaku Zasshi; 1979 Dec; 99(12):1234-9. PubMed ID: 544765
    [No Abstract]   [Full Text] [Related]  

  • 54. [Thiocyanatochromium(III) complexes with pilocarpine and the analytical determination of this alkaloid (author's transl)].
    Gănescu I; Várhelyi C; Brînzan G
    Arch Pharm (Weinheim); 1976 Nov; 309(11):887-92. PubMed ID: 1015999
    [No Abstract]   [Full Text] [Related]  

  • 55. [Thiocyanato-chrom(III)-complexes with nicotine and the analytical determination of this alkaloid (author's transl)].
    Gănescu I; Várhelyi C
    Arch Pharm (Weinheim); 1976 Apr; 309(4):251-7. PubMed ID: 962530
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemistry and biochemistry of gibberellin (author's transl)].
    Takahashi N
    Seikagaku; 1978 Mar; 50(3):184-8. PubMed ID: 659937
    [No Abstract]   [Full Text] [Related]  

  • 57. [Catalytic rearrangement of O,S-dialkyl dithiocarbonates to S,S-dialkyl dithiocarbonates. III. The reaction mechanism (author's transl)].
    Kawata T; Harano K; Taguchi T
    Yakugaku Zasshi; 1978 May; 98(5):600-4. PubMed ID: 660429
    [No Abstract]   [Full Text] [Related]  

  • 58. [Enzymatic cycling (author's transl)].
    Kato T
    Seikagaku; 1981; 53(4):262-4. PubMed ID: 7310192
    [No Abstract]   [Full Text] [Related]  

  • 59. [Contrast agents--requirements, possibilities, and risks (author's transl)].
    Herms HJ
    Neuroradiology; 1978; 16():482-6. PubMed ID: 745744
    [No Abstract]   [Full Text] [Related]  

  • 60. [The ethylenation of catechols (author's transl)].
    Fujita H; Yamashita M
    Yakugaku Zasshi; 1974 Sep; 94(9):1156-9. PubMed ID: 4476786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.